A decrease in overall inflammation from GLP-1's
Reviews (10) 5/5 Show 3 more reviews
VKTX's oral candidate achieved 12.2% weight loss at the highest dose in 13 weeks, matching or exceeding peers' metrics and showing potential for further improvement
Its bad news for compounding pharmacies, outsourcing facilities, and telehealth companies such as Hims & Hers selling cheaper alternatives to branded weight loss drugs
Asked for comment, Novo Nordisk did not address her individual case but has generally refuted such allegations
Research studies such as the SELECT trial, which used a 2.4 mg weekly dose, do not always specify the brand name, making data attribution to Ozempic or Wegovy sometimes unclear.12 Ozempic and Rybelsus are not currently recommended for pediatric populations